| # | Drug | Count |
|---|---|---|
| 0 | ASPIRIN | 131 |
| 1 | ASPIRIN 325 MG | 129 |
| 2 | ASPIRIN 81 MG | 129 |
| 3 | PANTOPRAZOLE | 89 |
| 4 | ESOMEPRAZOLE MAGNESIUM | 86 |
| 5 | METHOTREXATE SODIUM | 83 |
| 6 | OLMESARTAN MEDOXOMIL | 82 |
| 7 | OMEPRAZOLE MAGNESIUM | 79 |
| 8 | IBUPROFEN | 72 |
| 9 | METHOTREXATE | 72 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | NATRIUM MURIATICUM | 1 | 0.1429 |
| 1 | ANEMONE PATENS | 1 | 0.0667 |
| 2 | FENOPROFEN CALCIUM | 1 | 0.0204 |
| 3 | BETIBEGLOGENE AUTOTEMCEL | 1 | 0.0179 |
| 4 | AVANAFIL | 1 | 0.0143 |
| 5 | FERRIC SULFATE | 1 | 0.0125 |
| 6 | OLMESARTAN MEDOXOMIL-HYDROCHLOROTHIAZIDE | 67 | 0.0090 |
| 7 | OLMESARTAN MEDOXOMIL / AMLODIPINE BESYLATE / HYDROCHLOROTHIAZIDE | 8 | 0.0064 |
| 8 | AMLODIPINE BESYLATE AND OLMESARTAN MEDOXOMIL | 13 | 0.0052 |
| 9 | ESOMEPRAZOLE SODIUM | 12 | 0.0049 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nonsteroidal Anti-inflammatory Drug [EPC] | 264 |
| 1 | Platelet Aggregation Inhibitor [EPC] | 132 |
| 2 | Proton Pump Inhibitor [EPC] | 132 |
| 3 | Thiazide Diuretic [EPC] | 131 |
| 4 | HMG-CoA Reductase Inhibitor [EPC] | 109 |
| 5 | Corticosteroid [EPC] | 100 |
| 6 | Tumor Necrosis Factor Blocker [EPC] | 98 |
| 7 | Folate Analog Metabolic Inhibitor [EPC] | 73 |
| 8 | Angiotensin 2 Receptor Blocker [EPC] | 70 |
| 9 | Benzodiazepine [EPC] | 68 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Leptin Analog [EPC] | 2 | 0.0016 |
| 1 | Macrolide Antimicrobial [EPC] | 52 | 0.0010 |
| 2 | Dipeptidyl Peptidase 4 Inhibitor [EPC] | 29 | 0.0009 |
| 3 | Photoenhancer [EPC] | 3 | 0.0008 |
| 4 | Glucosylceramide Synthase Inhibitor [EPC] | 2 | 0.0007 |
| 5 | beta Lactamase Inhibitor [EPC] | 3 | 0.0007 |
| 6 | Calcitonin [EPC] | 2 | 0.0006 |
| 7 | Thiazide Diuretic [EPC] | 131 | 0.0006 |
| 8 | SLAMF7-directed Immunostimulatory Antibody [EPC] | 3 | 0.0006 |
| 9 | Interferon alfa-2b [EPC] | 1 | 0.0005 |